[Huaneng Power International, Inc. Huaneng Building No.6 Fuxingmennei Street Xicheng District, Beijing 100031 PRC Via EDGAR and Facsimile September 26, 2012 Jennifer Thompson Lisa Sellars 100 F Street, NE Facsimile Number: +1 (202) 772-9202 Re: Huaneng Power International, Inc. Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 19, 2012 File No. 001-13314 Dear Ms. Thompson and]
[Shanda Games Announces Adjustment of the Exercise Price of Share Options On September 14, 2012, the board of directors of Shanda Games Limited (Shanda Games or the Company) (Nasdaq: GAME), a leading online game developer, operator and publisher in China approved to adjust the exercise price for the share options held by the officers and employees of the Company and] [FORM 6-K Shanda Games Limited No. 1 Office Building x x n/a Shanda Games Limited Zhang Xiangdong Chief Executive Officer Description 99.1 Shanda Games Announces Adjustment of the Exercise Price of Share Options 6-K 1 htm_7049.htm LIVE FILING]
[Huaneng Power International, Inc. Huaneng Building No.6 Fuxingmennei Street Xicheng District, Beijing 100031 PRC Via EDGAR and Facsimile September 26, 2012 Jennifer Thompson Lisa Sellars 100 F Street, NE Facsimile Number: +1 (202) 772-9202 Re: Huaneng Power International, Inc. Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 19, 2012 File No. 001-13314 Dear Ms. Thompson and]
[Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President] [Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating] [Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 -- Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both] []
[Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President] [Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating] [Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 -- Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both] []
[Sinovac Holds 2012 Annual General Meeting of Shareholders BEIJING, Aug. 23, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2012 Annual General Meeting of Shareholders on Wednesday, August 22, 2012 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted] []
[Sinovac Holds 2012 Annual General Meeting of Shareholders BEIJING, Aug. 23, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2012 Annual General Meeting of Shareholders on Wednesday, August 22, 2012 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted] []
[Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer DHRM BEIJING, Sept. 21, 2012 /PRNewswire-FirstCall/ — Dehaier Medical Systems Ltd. (NASDAQ: During the three-year term of the agreement, the purchaser will procure Dehaier's proprietary air compressors, customized trolleys and accessories, which will be used in hospital intensive care units, emergency rooms, operation rooms, respiratory departments and] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): September 21, 2012 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Suite 501, Jiuzhou Plaza 83 Fuxing Road, Haidian District Beijing 100856 China +86 (10) 5166-0080 Not Applicable (Former name or former address, if changed since]
